Not Available, The British guidelines on asthma management: 1995 review and position statement. Thorax.
S1- S21Link to Article
National Asthma Education and Prevention Program, Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md National Institutes of Health1997;Publication 97-4051
BJ Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol.
1996;919- 27Link to Article
P Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol.
1982;22523- 529Link to Article
GH Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med.
19- 23Link to Article
M Biological activities of some corticosteroids used in asthma [abstract]. Am J Respir Crit Care Med. 1994;149
JE Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay [abstract]. Am J Respir Crit Care Med. 1994;149
et al. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16alpha, 17alphaacetal-substituted glucocorticoids. Mol Pharmacol. 1984;2570- 78
P Lipophilicity and receptor affinity of glucocorticoids. J Pharm Ztg Wiss. 1992;4161- 167
P Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids.
1994;59597- 602Link to Article
et al. Prolonged release from the airway tissue from glucocorticoids budesonide and fluticasone propionate as compared to beclomethasone dipropionate [abstract]. Am J Respir Crit Care Med. 1994;149
JE Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol. 1997;43155- 161
BJ Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol. 1996;42697- 705
R Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis. 1982;63
SM The human pharmacology of fluticasone propionate. Respir Med.
25- 29Link to Article
S Disposition of 14c triamcinolone acetonide administered as single oral dose of 100 Ci to healthy volunteers. Proceedings of a joint meeting of the American Academy of Allergy, Asthma Immunology and the American Thoracic Society, in cooperation with the American College of Chest Physicians, Asthma 1995 Conference, Theory to Treatment July 15-17, 1995 Chicago, Ill14
NI Flunisolide metabolism and dynamics of a metabolite. J Allergy Clin Immunol. 1980;27402- 413
A Biotransformation of the topical glucocorticoids, budesonide and beclomethasone, 17,21-diaproprionate in human liver and lung homogenate. J Pharm Pharmacol.
1984;36763- 765Link to Article
TB Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (P-MDI). Eur Respir J.
1998;71839- 1844Link to Article
S Pharmacokinetics of triamcinolone acetonide after intravenous, oral and inhaled administration. J Clin Pharmacol.
1995;35302- 305Link to Article
GP Pharmacokinetics and systemic exposure of inhaled beclomethasone dipropionate [abstract]. Eur Respir J. 1996;9
A An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol.
1994;38521- 525Link to Article
A An assessment of the systemic effects of single repeated doses of inhaled fluticasone propionate, in inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol.
1996;49459- 463Link to Article
GK Do large volume spacer devices reduce systemic effects of high dose inhaled corticosteroids. Thorax.
1990;45736- 739Link to Article
M Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry-powder inhaler. Thorax.
1991;46891- 894Link to Article
GK Systemic effects of high dose inhaled steroids: comparison of beclomethasone and budesonide in healthy subjects. Thorax.
1993;48967- 973Link to Article
SA Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis. 1983;129723- 729
A Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J.
1996;91427- 1432Link to Article
JP Effects of budesonide and fluticasone on 24-hour plasma cortisol: a dose-response study. Am J Respir Crit Care Med.
1997;1561746- 1751Link to Article
et al. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Eur J Clin Pharmacol.
1997;52261- 267Link to Article
BJ Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax.
1997;5255- 58Link to Article
SI A comparison of fluticasone propionate 1 mg daily, with beclomethasone dipropionate 2 mg daily, in the treatment of severe asthma. Eur Respir J. 1993;6877- 884
et al. Evaluation of fluticasone propionate (500 µg/day) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone type propionate (1000 µg/day) administered by pressurized inhaler. Respir Med.
1993;87609- 620Link to Article
TAG Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison of 1 year. Respir Med.
1996;90609- 617Link to Article
CLA Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med.
1996;153924- 930Link to Article
DJ Effects of airway calibre on the lung delivery of nebulised salbutamol. Thorax.
1997;521036- 1039Link to Article
M Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol.
1995;144401- 410Link to Article
JL Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax.
1997;52476- 482Link to Article
TAJ High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J. 1995;8579- 586
et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax.
1993;48817- 833Link to Article
BJ A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol.
1994;38527- 532Link to Article
AM Dose response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults [abstract]. J Allergy Clin Immunol. 1998;101
et al. Efficacy of inhaled fluticasone propionate in asthma results from topical and not systemic activity. Am J Respir Crit Care Med.
1997;156447- 451Link to Article
BJ Dose response effect for adrenal suppression with repeated twice daily inhaled fluticasone priopionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med.
1997;1561274- 1277Link to Article
S A randomised double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol.
1997;99773- 780Link to Article
BJ Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax.
1996;51262- 266Link to Article
et al. Effects of inhaled fluticasone propionate on the HPA-axis of patients with asthma. Eur Respir J. 1996;9
et al. Adrenal suppression amongst asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol.
1996;76234- 238Link to Article
BJ Adrenal suppression with inhaled budesonide and fluticasone propionate given by a large volume spacer in asthmatic children. Thorax.
1996;51941- 943Link to Article
et al. A bioassay for topical and systemic effect of 3 inhaled corticosteroids. Clin Pharmacol Ther.
1995;57445- 460Link to Article
et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol.
1994;94676- 683Link to Article
G Effective high doses of inhaled corticosteroids on adrenal function in children with severe persistant asthma. Thorax.
1993;48599- 602Link to Article
et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest.
1993;1041352- 1358Link to Article
et al. Adrenal function in adult asthmatics during long-term daily treatment with 800, 1200 and 1600 µg triamcinolone acetonide. Chest.
1992;1011250- 1256Link to Article
JW Adrenal function in asthma. Arch Dis Child.
1990;65838- 840Link to Article
et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol.
1988;811088- 1095Link to Article
G Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J. 1988;1433- 435
DM Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax. 1995;51281- 284
et al. Low dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995;801243- 1246
GK Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high doses of inhaled corticosteroid. Respir Med.
1991;85511- 516Link to Article
CGD The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol.
1991;130475- 479Link to Article
CGD Reproducibility of the cortisol response to simulation with a low dose of ACTH (1-24): the effect of basal cortisol levels in comparison of low dose with high dose secretory dynamics. J Endocrinol.
1993;136167- 172Link to Article
E A low dose ACTH test to access the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol.
1991;44151- 156Link to Article
B Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med.
1995;8S13- S19Link to Article
BJ Systemic dose-response relationships with oral and inhaled corticosteroid in asthmatics. Thorax.
A57Link to Article
SA Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin.
1989;84688- 700Link to Article
et al. Fluticasone propionate reduces oral prednisolone use while it improves asthma control and quality of life. Am J Respir Crit Care Med.
1995;1521467- 1473Link to Article
S Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J.
1997;101507- 1512Link to Article
JW Adrenal function and high dose inhaled corticosteroid for asthma. Arch Dis Child.
1997;76405- 410Link to Article
LC Adrenocortical activity with repeated twice daily dosing of inhaled fluticasone propionate and budesonide given via large volume spacer to asthmatic school children. Thorax.
1997;52686- 689Link to Article
J Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Paediatr Pulmonol.
1997;3178- 186Link to Article
ST Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med.
1995;1511715- 1719Link to Article
S Measures of systemic activity of inhaled corticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med.
1995;89347- 349Link to Article
E Comparison of the efficacy and safety of inhaled fluticasone propionate 200 µg/day with inhaled beclomethasone dipropionate 400 µg/day in mild and moderate asthma. Arch Dis Child.
1993;69206- 211Link to Article
JO Endocrine and lung function in asthmatic children treated with inhaled budesonide. Am J Respir Crit Care Med.
1994;150624- 628Link to Article
I Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide. J Allergy Clin Immunol.
1995;96874- 878Link to Article
K A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Paediatr.
1993;152856- 860Link to Article
P Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exper Allergy.
1991;21145- 146Link to Article
J Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol.
1990;85914- 920Link to Article
I Effects of inhaled corticosteroids on hypothalamo-pituitary-adrenal function and growth in children. Res Clin Forums. 1989;1177- 86
H Adrenocortical function in children on high-dose steroid aerosol therapy: results of serum cortisol, ACTH stimulation test and 24 hour urinary free cortisol excretion. Allergy.
1987;42541- 544Link to Article
S Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child.
1987;62815- 819Link to Article
D A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br J Dis Chest.
1987;81170- 175Link to Article
JO Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet. 1996;1942- 944
JO Asthma treatment with a new corticosteroid aerosol budesonide administered twice daily by spacer inhaler. Arch Dis Child.
1982;57864- 866Link to Article
ME Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax.
1983;38676- 681Link to Article
GK Hypothalamo-pituitary-adrenal axis suppression in asthmatics taking inhaled high dose corticosteroids. Respir Med.
1990;85501- 510Link to Article
BJ Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. J Clin Endocrinol Metab.
1998;83922- 925Link to Article
JVan Den Burgt
J Beneficial effects of reduced particle size of CFC-free extra fine aerosol steroid on lung deposition, absorption, efficacy and safety [abstract]. Am J Respir Crit Care Med. 1997;155
S Inhaled corticosteroids: the endocrinologist's view. Eur Respir Rev. 1993;3494- 500
H Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J Allergy Clin Immunol.
1982;69208- 212Link to Article
BJ Adrenocortical activity with repeated administration of once daily inhaled fluticasone propionate and budesonide in asthmatic adults. Eur J Clin Pharmacol.
1998;153317- 320Link to Article
S High-dose inhaled steroids in asthmatic children. Lancet.
1996;384820- 821Link to Article
SA Assessment of systemic effects of inhaled glucocorticoids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol.
1989;4077- 82Link to Article
BJ A chronic dosing comparison of the systemic bioactivity with oral prednisolone and nebulised budesonide in adult asthmatic patients [abstract]. Br J Clin Pharmacol. 1998;45185P
S Bone mineral density on children with asthma receiving long term treatment with inhaled budesonide. Am J Respir Crit Care Med.
1998;157178- 183Link to Article
et al. Growth in asthmatic children treated with fluticasone propionate. J Paediatr.
1998;132472- 477Link to Article
et al. Effect of asthma and its treatment on growth: four year follow-up of cohort of children from general practice in Tayside, Scotland. BMJ.
1998;316688- 692Link to Article
FER A comparison of beclomethasone, sameterol and placebo in children with asthma. N Engl J Med.
1997;3371659- 1665Link to Article
et al. One-year treatment with salmeterol compared to beclomethasone in children with asthma. Am J Crit Care Med.
1997;156688- 695Link to Article
et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol.
1997;99466- 474Link to Article
S Effects of long term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med.
1994;88373- 381Link to Article
KP Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;9264- 77
PH Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics. 1993;911121- 1126
AE Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet. 1998;1115- 116
K Extrapulmonary effects of maintenance corticosteroid therapy with alternate day prednisolone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol.
1987;80518- 529Link to Article
S Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child.
1993;68673- 676Link to Article
S Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics. 1992;89839- 842
S Growth of asthmatic children during treatment with budesonide: a double-blind trial. BMJ.
1991;303163- 165Link to Article
JK Growth in asthmatic children [letter]. BMJ. 1991;303416
S Relationship between short term lower leg growth and long term statural growth in asthmatic children treated with budesonide [abstract]. Eur Respir J. 1996;9
B A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol.
1994;93967- 976Link to Article
L Growth and childhood asthma. Arch Dis Child.
1986;611049- 1055Link to Article
R Bone mass measurement: prediction of risk. Am J Med.
6S- 10SLink to Article
K Oral and inhaled corticosteroids reduced bone formation as shown by plasma osteocalcin levels. Am Rev Respir Dis.
1995;151333- 336Link to Article
BJ Effects of short-term exposure to high dose inhaled corticosteroids on novel markers of bone metabolism. Eur J Clin Pharmacol.
1996;5275- 277Link to Article
JC Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab.
1991;72530- 540Link to Article
PR Inhaled corticosteroids, bone formation, and osteocalcin. Lancet.
1991;33860- 61Link to Article
AE Cross section investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. Thorax.
1997;52853- 860Link to Article
DJ High dose inhaled steroids in asthmatic children [letter]. Lancet.
1996;348820Link to Article
S Dose related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol.
1995;96571- 579Link to Article
et al. Effects of short-term and long-term treatment with inhaled corticosteroids of bone metabolism in patients with airways obstruction. Thorax.
1994;49652- 656Link to Article
S Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor access and collagen turnover in children treated with inhaled glucocorticosteroids. Paediatr Res.
1997;4144- 50Link to Article
C Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child.
1995;73524- 527Link to Article
C Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Paediatr.
1993;122219- 226Link to Article
A Effect of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol.
1992;9808- 815Link to Article
C Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J.
1997;102110- 2113Link to Article
AL Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med.
1996;153232- 236Link to Article
et al. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol.
1995;96157- 166Link to Article
M Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest.
1994;1051722- 1727Link to Article
F Effect of beclomethasone dipropionate on bone mineral content assessed by x-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J.
1994;7710- 714Link to Article
MM Bone mineral density in asthmatic women on high dose inhaled beclomethasone dipropionate. Bone.
1994;15621- 623Link to Article
DM Bone density in asthmatic patients taking high dose inhaled beclomethasone and intermittent systemic corticosteroids. Thorax.
1992;47414- 417Link to Article
E Corticosteroid induced cataracts. Surv Ophthalmol.
1986;31102- 110Link to Article
TJC Steroid aerosols and cataract formation [letter]. BMJ.
1989;299918Link to Article
SM Posterior subcapsular cataracts associated with nasal or inhaled corticosteroids. Am J Ophthalmol. 1990;109489- 490
P Steroid aerosols and cataract formation. BMJ.
1989;299432- 433Link to Article
HCJ Posterior subcapsular cataracts in steroid requiring asthmatic children. J Allergy Clin Immunol.
1979;63383- 386Link to Article
JM Dynamic nature of posterior subcapsular cataract. Br J Ophthalmol.
1989;73522- 527Link to Article
C Association of ocular cataracts with inhaled and oral steroid therapy during long term treatment of asthma. J Allergy Clin Immunol.
1993;91571- 579Link to Article
EP Absence of posterior subcapsula cataracts in young patients treated with inhaled glucocorticoids. Lancet.
1993;342776- 778Link to Article
G Posterior subcapsula cataract and inhaled corticosteroid therapy. Thorax.
1995;50674- 676Link to Article
SR Use of inhaled corticosteroids and the risks of cataracts. N Engl J Med.
1997;3378- 14Link to Article
ST Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology.
1995;102177- 179Link to Article
EB Inhaled steroid use and glaucoma [letter]. N Engl J Med.
1993;3291822Link to Article
S Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA.
1997;277722- 727Link to Article
AY Pupura and dermal thinning associated with high dose inhaled corticosteroids. BMJ.
1990;3001548- 1551Link to Article
SG Easy bruising is a side effect of inhaled corticosteroids. Eur Respir J. 1992;51068- 1074
et al. Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency in association with adrenal function. Eur Respir J.
1996;9226- 231Link to Article